Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
Efficacy and Safety of Switching to Dolutegravir/Lamivudine in Virologically Suppressed HIV-1 Infected Adults with TDF-Related Renal or Bone Toxicity
Saved in:
| Published in: | Infectious Diseases and Therapy |
|---|---|
| Format: | Online Article RSS Article |
| Published: |
2026
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
| _version_ | 1867301677762084868 |
|---|---|
| collection | WordPress RSS FRELIP Feed Integration |
| container_title | Infectious Diseases and Therapy |
| description | |
| discipline_display | Communicable Diseases, Epidemiology |
| discipline_facet | Communicable Diseases, Epidemiology |
| format | Online Article RSS Article |
| genre | Journal Article |
| id | rss_article:79367 |
| institution | FRELIP |
| journal_source_facet | Infectious Diseases and Therapy |
| publishDate | 2026 |
| publishDateSort | 2026 |
| record_format | rss_article |
| spellingShingle | Efficacy and Safety of Switching to Dolutegravir/Lamivudine in Virologically Suppressed HIV-1 Infected Adults with TDF-Related Renal or Bone Toxicity Communicable Diseases, Epidemiology General Communicable Diseases, Epidemiology |
| sub_discipline_display | General |
| sub_discipline_facet | General |
| subject_display | Communicable Diseases, Epidemiology General Communicable Diseases, Epidemiology Communicable Diseases, Epidemiology General Communicable Diseases, Epidemiology |
| subject_facet | Communicable Diseases, Epidemiology General Communicable Diseases, Epidemiology |
| title | Efficacy and Safety of Switching to Dolutegravir/Lamivudine in Virologically Suppressed HIV-1 Infected Adults with TDF-Related Renal or Bone Toxicity |
| title_auth | Efficacy and Safety of Switching to Dolutegravir/Lamivudine in Virologically Suppressed HIV-1 Infected Adults with TDF-Related Renal or Bone Toxicity |
| title_full | Efficacy and Safety of Switching to Dolutegravir/Lamivudine in Virologically Suppressed HIV-1 Infected Adults with TDF-Related Renal or Bone Toxicity |
| title_fullStr | Efficacy and Safety of Switching to Dolutegravir/Lamivudine in Virologically Suppressed HIV-1 Infected Adults with TDF-Related Renal or Bone Toxicity |
| title_full_unstemmed | Efficacy and Safety of Switching to Dolutegravir/Lamivudine in Virologically Suppressed HIV-1 Infected Adults with TDF-Related Renal or Bone Toxicity |
| title_short | Efficacy and Safety of Switching to Dolutegravir/Lamivudine in Virologically Suppressed HIV-1 Infected Adults with TDF-Related Renal or Bone Toxicity |
| title_sort | efficacy and safety of switching to dolutegravir/lamivudine in virologically suppressed hiv-1 infected adults with tdf-related renal or bone toxicity |
| topic | Communicable Diseases, Epidemiology General Communicable Diseases, Epidemiology |
| url | https://link.springer.com/article/10.1007/s40121-026-01363-y |